Amphastar Pharmaceuticals
AMPH
28.25
+0.14
+0.50%
Amphastar Pharmaceuticals
US · AMPH
#3194 by market cap
28.25
+0.14
+0.50%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
A+
Momentum strategy signal
Hold
Analyst consensus
Sell
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
3
■ Upgrades■ Downgrades
- 0 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Hold to Sell on 2026-06-29.
Analyst consensus 2 analysts
Sell
Avg price target 23.00 -18.6%
Price target rangecurrent 28.25
Low23.00
Avg23.00
High23.00
Buy 0%
Hold 50%
Sell 50%
Recent ratings (24)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | BofA Securities | -- | Sell | 23.00 |
| 2026-08-18 | Barclays | -- | Hold | 23.00 |
| 2026-08-07 | Wells Fargo | -- | Hold | 20.00 |
| 2026-08-07 | Piper Sandler | -- | Hold | 20.00 |
| 2026-08-07 | Needham | -- | Hold | 20.00 |
| 2026-07-08 | Needham | -- | Hold | -- |
| 2026-06-29 | BofA Securities | -- | Sell | 20.00 |
| 2026-06-03 | Barclays | -- | Hold | 20.00 |
| 2026-05-14 | Wells Fargo | -- | Hold | 19.00 |
| 2026-05-11 | Piper Sandler | -- | Hold | 21.00 |
| 2026-05-08 | Needham | -- | Hold | -- |
| 2026-04-15 | Needham | -- | Buy | 30.00 |
| 2026-04-07 | Barclays | -- | Hold | 23.00 |
| 2026-02-27 | Needham | -- | Buy | 30.00 |
| 2026-02-24 | Needham | -- | Buy | 34.00 |
| 2026-01-20 | BofA Securities | -- | Hold | 30.00 |
| 2026-01-07 | BofA Securities | -- | Hold | 30.00 |
| 2025-12-17 | Wells Fargo | -- | Buy | 34.00 |
| 2025-12-15 | Needham | -- | Buy | 34.00 |
| 2025-12-08 | Barclays | -- | Hold | 30.00 |
| 2025-11-07 | Piper Sandler | -- | Hold | 25.00 |
| 2025-11-07 | Needham | -- | Buy | 34.00 |
| 2025-10-22 | Needham | -- | Buy | 36.00 |
| 2025-10-09 | BofA Securities | -- | Hold | 31.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-29 | BofA Securities | Hold → Sell | 20.00 |
| 2026-05-14 | Wells Fargo | Buy → Hold | 19.00 |
| 2026-05-08 | Needham | Buy → Hold | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | After close | ±16.62% | +3.00% (in line) |
| 2026/Q2 | 2026-08-06 | After close | -- | +4.90% |
| 2026/Q1 | 2026-05-07 | After close | ±16.35% | -20.93% (beat) |
| 2025/Q4 | 2026-02-26 | After close | ±11.89% | -23.63% (beat) |
| 2025/Q3 | 2025-11-06 | After close | -- | -0.83% |
| 2025/Q2 | 2025-08-07 | After close | ±12.02% | +10.13% (in line) |
| 2025/Q1 | 2025-05-07 | After close | ±19.52% | +0.90% (in line) |
| 2024/Q4 | 2025-02-27 | After close | ±12.42% | -9.72% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±10.30% | -13.69% (beat) |
| 2024/Q2 | 2024-08-07 | After close | ±16.57% | +13.29% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±14.45% | +0.52% (in line) |
| 2023/Q4 | 2024-02-28 | After close | ±15.18% | -14.93% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Amphastar Pharmaceuticals discussion 0 comments